Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

Sweden

Switzerland

France

United Kingdom

Netherlands

United States

Investments

07 November 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Artios Pharma (company)

United Kingdom

Health services Manufacturing Pharma

Total investments received (USD): 115M

Round value (USD): 115M

Round investors: EQT Partners TCGX SV Health Investors Andera Partners Janus Henderson RA Capital Management Omega Funds Merck Ventures Avidity Partners Schroders Novartis Venture Fund Invus Pfizer Venture Investments IP Group

Company: Artios Pharma

Industry: Health services Manufacturing Pharma

Related deals

OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Health services Manufacturing

United Kingdom

Japan

Secondary 14 July 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top